|
Characteristics of the 420 Patients Enrolled in the Stroke Outcome Study from 2001–2002 at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada |
|
| Characteristic |
n (%)a |
|
|
|
| Sex |
|
| Male |
234 (55.7) |
| Female |
186 (44.3) |
| Age (years) |
68.2 ± 13.8 |
| < 65 |
138 (32.9) |
| 65–79 |
198 (47.1) |
| ≥ 80 |
84 (20.0) |
| History of previous stroke (n = 418) |
109 (26.1) |
| Length of hospital stay (days) |
16.2 ± 21.1 |
| Stroke subtype |
|
| Partial anterior circulation |
132 (31.4) |
| Lacunar |
106 (25.2) |
| Posterior circulation |
79 (18.8) |
| Total anterior circulation |
30 (7.1) |
| Transient ischemic attack |
59 (14.0) |
| Uncertain |
14 (3.3) |
| Stroke severity |
|
| Transient ischemic attack |
35 (8.4) |
| Mild |
90 (21.5) |
| Moderate |
226 (53.9) |
| Severe |
68 (16.2) |
| Unknown |
1 (0.002) |
| Disability at discharge |
|
| Independent |
333 (79.3) |
| Dependent |
87 (20.7) |
| Cognitive impairment at discharge |
|
| Not impaired |
111 (26.4) |
| Impaired |
84 (20.0) |
| Missing |
225 (53.6) |
| Atrial fibrillation (n = 418) |
60 (14.4) |
| Average household income (n = 386) |
$55,472 ± 19,370 |
| Total medications prescribedb |
6.4 ± 2.6 |
| Total doses taken per dayb |
8.6 ± 4.5 |
| Monthly cost of prescription drugsc |
$167.10 ± 99.47 |
|
aValues expressed as number (%) or mean ± standard deviation, n = 420 unless otherwise noted bIncludes all prescription and non-prescription medications ordered by a physician at time of discharge cIncludes only community prescription drug costs at time of discharge excluding pharmacist's professional fees | |
Lummis et al. BMC Neurology 2008 8:25 doi:10.1186/1471-2377-8-25 |
|